Drug shortage: Pentostatin Injection (NIPENT)
FDA lists 1 presentation as Current. Availability: Unavailable (1). Reason: Other. Companies: Hospira, Inc., a Pfizer Company.
- Published by source
- 2026-08-27
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Pentostatin Injection NIPENT
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Next Delivery: April 2027; Estimated Recovery: June 2027. Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-08-27
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #971 | new | 2026-10-22 | 0a68b74e29a6…da01e9 | cf37129f8b75…8a2cac |
Chain head: #1076 8ad5adc30b9b…88ce20